Dr. Lazo-Diaz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1901 S 2nd St
McAllen, TX 78503Phone+1 956-687-5150Fax+1 956-687-9546
Summary
- Dr. Guillermo Lazo-Diaz is a seasoned Oncologist based in McAllen, Texas, who has specialized training in Hematologic Oncology and Hospice & Palliative care. He completed his medical education and fellowships in top institutions, including the University of Kansas School of Medicine, where he specialized in Internal Medicine, and the University of Texas MD Anderson Cancer Center, where he completed an internship and fellowship in Hematology and Medical Oncology.
His expertise extends to conditions such as, myelodysplasia, myelofibrosis, and multiple myeloma. Dr. Lazo-Diaz has contributed to oncology research, with his work published in reputed journals, most notably for his work on arsenic trioxide's use in treating acute promyelocytic leukemia. Furthermore, he has been recognized by the Centers for Medicare & Medicaid Services with the Meaningful Use Stage 1 Certification in 2012.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2001 - 2004
University of Kansas School of MedicineResidency, Internal Medicine, 1997 - 2000- University of Texas Health Science Center at HoustonInternship, Transitional Year, 1996 - 1997
Universidad Autonoma de Nuevo LeonClass of 1995
Certifications & Licensure
TX State Medical License 2000 - 2026
National Board of Physicians and Surgeons Internal Medicine- National Board of Physicians and Surgeons Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 426 citationsUse of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: the M. D. Anderson experience.Guillermo Lazo, Hagop Kantarjian, Elihu Estey, Deborah Thomas, Susan O'Brien
Cancer. 2003-05-01
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
